Neutrophils activated by granulocyte-macrophage colony-stimulating factor express receptors for interleukin-3 which mediate class II expression

dc.contributor.authorSmith, W.
dc.contributor.authorGuida, L.
dc.contributor.authorQiuy, S.
dc.contributor.authorKorpelainen, E.
dc.contributor.authorvan den Hueven, C.
dc.contributor.authorGillis, D.
dc.contributor.authorHawrylowicz, C.
dc.contributor.authorVadas, M.
dc.contributor.authorLopez, A.
dc.date.issued1995
dc.description.abstractFreshly isolated peripheral blood neutrophils, unlike monocytes and eosinophils, do not bind interleukin-3 (IL-3) or respond to IL-3). We show that neutrophils cultured for 24 hours in granulocyte-macrophage colony-stimulating factor (GM-CSF) express mRNA for the IL-3 receptor (R) alpha subunit, as shown by RNase protection assays, and IL-3R alpha chain protein, as shown by cytometric analysis using two different specific monoclonal antibodies. This effect was selective for GM-CSF, because granulocyte colony-stimulating factor, tumor necrosis factor- alpha, interferon-gamma, and IL-1 failed to induce the IL-3 receptor. Saturation binding curves with 125I-IL-3 and Scatchard transformation showed the presence of about 100 high-affinity and 4,000 low-affinity receptors. Because neutrophils have been shown to express human leukocyte antigen (HLA)-DR in response to GM-CSF, we examined the possibility that IL-3 could augment HLA-DR expression on GM-CSF-treated cells. We found that neutrophils incubated with 30 ng/mL IL-3 as well as 0.1 ng/mL GM-CSF expressed a mean of 2.1-fold higher levels of HLA- DR than with GM-CSF alone (P < .005), confirming the signaling competence of the newly expressed IL-3R. This increase was seen even at maximal concentrations of GM-CSF and IL-3 can have an additive effect on mature human cells. The augmentation of HLA-DR by IL-3 was specific because it could be inhibited by a blocking anti-IL-3R antibody. Expression of class II molecules by neutrophils under these conditions may have significance for antigen presentation. These results provide further evidence for the role of GM-CSF as an amplification factor in inflammation by inducing neutrophil responsiveness to IL-3 produced by T cells or mast cells.
dc.description.statementofresponsibilityWB Smith, L Guida, Q Sun, EI Korpelainen, C van den Heuvel, D Gillis, CM Hawrylowicz, MA Vadas, and AF Lopez
dc.identifier.citationBlood, 1995; 86(10):3938-3944
dc.identifier.doi10.1182/blood.v86.10.3938.bloodjournal86103938
dc.identifier.issn0006-4971
dc.identifier.issn1528-0020
dc.identifier.orcidSmith, W. [0000-0001-9640-1172] [0000-0002-4610-998X]
dc.identifier.orcidLopez, A. [0000-0001-7430-0135]
dc.identifier.urihttp://hdl.handle.net/2440/11539
dc.language.isoen
dc.publisherAmerican Society of Hematology
dc.rights© 1995 by The American Society of Hematology
dc.source.urihttp://www.bloodjournal.org/content/86/10/3938
dc.subjectNeutrophils
dc.subjectCells, Cultured
dc.subjectHumans
dc.subjectGranulocyte-Macrophage Colony-Stimulating Factor
dc.subjectInterleukin-3
dc.subjectReceptors, Granulocyte-Macrophage Colony-Stimulating Factor
dc.subjectReceptors, Interleukin-3
dc.subjectRecombinant Proteins
dc.subjectRNA, Messenger
dc.subjectHLA-D Antigens
dc.subjectFlow Cytometry
dc.subjectSignal Transduction
dc.subjectNeutrophil Activation
dc.subjectGene Expression Regulation
dc.titleNeutrophils activated by granulocyte-macrophage colony-stimulating factor express receptors for interleukin-3 which mediate class II expression
dc.typeJournal article
pubs.publication-statusPublished

Files